Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 228,863,343 papers from all fields of science
Search
Sign In
Create Free Account
Chemotherapy Regimen
Known as:
cancer pharmacotherapy
, neoplasm chemotherapy
, chemo
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
15 relations
Antineoplastic Agents
Chemotherapy:Prid:Pt:Cancer.XXX:Nom
Crotoxin
Pharmacotherapy
Expand
Broader (1)
Chemotherapy
Narrower (8)
Chemotherapy Regimen or Agent Combination
chemoprevention of cancer
chemosensitization/potentiation
cyclophosphamide/losoxantrone
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
The Schedule-Dependent Effects of the Novel Antifolate Pralatrexate and Gemcitabine Are Superior to Methotrexate and Cytarabine in Models of Human Non-Hodgkin's Lymphoma
L. Toner
,
R. Vrhovac
,
+6 authors
O. O’Connor
Clinical Cancer Research
2006
Corpus ID: 9583262
Purpose: Methotrexate is known to synergize with cytarabine [1-β-d-arabinofuranosylcytosine (ara-C)] in a schedule-dependent…
Expand
Highly Cited
2005
Highly Cited
2005
Interim report of a phase II clinical trial of bevacizumab (Bev) and low dose metronomic oral cyclophosphamide (mCTX) in recurrent ovarian (OC) and primary peritoneal carcinoma: A California Cancer…
Agustin A. Garcia
,
A. Oza
,
+7 authors
R. Morgan
2005
Corpus ID: 74188828
5000 Background: Bev is a recombinant humanized anti-VEGF monoclonal antibody that inhibits the growth of a number of human…
Expand
Highly Cited
2005
Highly Cited
2005
Docetaxel and cyclooxygenase-2 inhibition with celecoxib for advanced non-small cell lung cancer progressing after platinum-based chemotherapy: a multicenter phase II trial.
F. Nugent
,
W. Mertens
,
+5 authors
J. McCann
Lung Cancer
2005
Corpus ID: 7431768
Review
2004
Review
2004
Management of multifocal primary cutaneous CD30 anaplastic large cell lymphoma.
J. Shehan
,
A. Kalaaji
,
S. Markovic
,
I. Ahmed
Journal of American Academy of Dermatology
2004
Corpus ID: 10669213
Review
2002
Review
2002
Anti‐human epidermal growth factor receptor 2 monoclonal antibody therapy for breast cancer
D. Leonard
,
A. Hill
,
L. Kelly
,
B. Dijkstra
,
E. McDermott
,
N. O’higgins
British Journal of Surgery
2002
Corpus ID: 23076055
Advances in molecular biology and improved understanding of tumour biology have led to the development of novel treatments for…
Expand
Highly Cited
1999
Highly Cited
1999
Salvage chemotherapy with tamoxifen for recurrent anaplastic astrocytomas.
M. Chamberlain
,
P. Kormanik
Archives of Neurology
1999
Corpus ID: 8460816
BACKGROUND A prospective phase 2 study of daily oral tamoxifen citrate in young adults with recurrent anaplastic astrocytomas…
Expand
Highly Cited
1998
Highly Cited
1998
Dose-effect relations for early local pulmonary injury after irradiation for malignant lymphoma and breast cancer.
J. Theuws
,
S. Kwa
,
+5 authors
J. Lebesque
Radiotherapy and Oncology
1998
Corpus ID: 22670688
Highly Cited
1995
Highly Cited
1995
Overexpression of p53 Predicts Organ Preservation Using Induction Chemotherapy and Radiation in Patients with Advanced Laryngeal Cancer
C. Bradford
,
Shaobo Zhu
,
+5 authors
T. Carey
Otolaryngology Head & Neck Surgery
1995
Corpus ID: 39847412
Review
1991
Review
1991
Randomized trials of induction chemotherapy. A critical review.
A. A. Forastiere
Hematology/Oncology Clinics of North America
1991
Corpus ID: 23427401
Highly Cited
1981
Highly Cited
1981
High dose chemotherapy and autologous bone marrow transplantation in acute leukemias, malignant lymphomas and solid tumors. A study of 23 patients.
N. Gorin
,
R. David
,
+5 authors
G. Duhamel
European Journal of Cancer
1981
Corpus ID: 30701673
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE